Indirubin-3′-monoxime exhibits potent antiviral and anti-inflammatory effects against human adenoviruses in vitro and in vivo
Authors:
Open Access
- 10 April 2024
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 174, 116558
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82102435)
- Natural Science Foundation of Beijing Municipality (7212142)
This publication has 47 references indexed in Scilit:
- A novel humanized tri‐receptor transgenic mouse model of HAdV infection and pathogenesisJournal of Medical Virology, 2023
- Pharmacological properties of indirubin and its derivativesBiomedicine & Pharmacotherapy, 2022
- Emerging antiviral therapeutics for human adenovirus infection: Recent developments and novel strategiesAntiviral Research, 2021
- A standardized approach to the evaluation of antivirals against DNA viruses: Orthopox-, adeno-, and herpesvirusesAntiviral Research, 2018
- USC-087 protects Syrian hamsters against lethal challenge with human species C adenovirusesAntiviral Research, 2018
- Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II TrialTransplantation and Cellular Therapy, 2017
- Discovery of novel indirubin-3′-monoxime derivatives as potent inhibitors against CDK2 and CDK9Bioorganic & Medicinal Chemistry Letters, 2015
- Anti-inflammatory and antiviral effects of indirubin derivatives in influenza A (H5N1) virus infected primary human peripheral blood-derived macrophages and alveolar epithelial cellsAntiviral Research, 2014
- Indirubin-3-monoxime exhibits anti-inflammatory properties by down-regulating NF-κB and JNK signaling pathways in lipopolysaccharide-treated RAW264.7 cellsInflammation Research, 2011
- The cotton rat model for adenovirus ocular infection: antiviral activity of cidofovir.Antiviral Research, 2003